Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,935
Closed -$961K 169
2025
Q4
$961K Sell
2,935
-668
-19% -$212K 0.2% 101
2025
Q3
$1.02M Buy
+3,603
New +$1.04M 0.16% 68
2023
Q2
Sell
-268
Closed -$15.8M 197
2023
Q1
$15.8M Buy
+268
New +$65.8K 0.1% 104
2022
Q4
Sell
-431
Closed -$96K 178
2022
Q3
$96K Hold
431
0.1% 76
2022
Q2
$104K Buy
431
+228
+112% +$55.9K 0.07% 85
2022
Q1
$49K Hold
203
0.03% 58
2021
Q4
$45K Buy
+203
New +$42.8K 0.03% 57
2021
Q3
Sell
-203
Closed -$49K 21
2021
Q2
$49K Hold
203
0.04% 39
2021
Q1
$50K Buy
+203
New +$48.4K 0.04% 39

Other funds holding AMGN

Mach-1 Financial Group's AMGN Position: Q1 2026 in Review

Mach-1 Financial Group sold out of Amgen (AMGN) in Q1 2026, closing a stake of 2,935 shares — an estimated $961K sold.

Mach-1 Financial Group first reported a position in AMGN in Q1 2021 and held it in 9 quarters. The position peaked at $15.8M in Q1 2023. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Mach-1 Financial Group reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Mach-1 Financial Group sold 2,935 Amgen shares in Q1 2026, an estimated $961K.
  • Mach-1 Financial Group first reported a position in Amgen in Q1 2021 and held it in 9 quarters.
  • Mach-1 Financial Group's Amgen position peaked at $15.8M in Q1 2023.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Mach-1 Financial Group's 13F filing for Q1 2026, filed 13 May 2026.